HCV - Liver Fibrosis

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08

Non-invasive Markers for Liver Fibrosis in Hepatitis C Patients with Normal ALT - 3/11/08

Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis - 2/29/08

Genetic Variations in HCV Genotype 3 Core Protein Promote Liver Fat Accumulation - 2/26/08

Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy - 2/05/08

Frequent Cannabis Use is Associated with Liver Fibrosis Progression in Hepatitis C Patients - 1/25/08

Use of CT Scans to Monitor Liver Fibrosis in People with Hepatitis C - 1/14/08

Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients - 12/11/07

Liver Stiffness Measurement (FibroScan) More Useful for Assessing Fibrosis in Patients with HCV Compared with HBV- 12/04/07

Natural History of Hepatitis C in Patients with Severe Liver Fibrosis    - 7/10/07

FIB-4: An Inexpensive and Accurate Marker of Liver Fibrosis in Patients with Hepatitis C    - 7/03/07

Comparison of 6 Non-invasive Measures for Diagnosing Liver Fibrosis in Hepatitis C Patients    - 6/19/07

Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients  - 5/01/07

Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV-HCV Coinfected Patients  - 3/20/07